Tokuda Michifumi, Kojodjojo Pipin, Tung Stanley, Inada Keiichi, Matsuo Seiichiro, Yamane Teiichi, Yoshimura Michihiro, Tedrow Usha B, Stevenson William G
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Division of Cardiology, The Jikei University School of Medicine, Tokyo, Japan.
J Cardiovasc Electrophysiol. 2016 Jan;27(1):88-94. doi: 10.1111/jce.12873. Epub 2015 Dec 14.
Optimal procedure endpoints of catheter ablation for ventricular tachycardia (VT) are not defined and multiple repeat procedures are sometimes required. However, there are few studies to compare the details of repeat procedures to the initial procedure. The aim of this study is to compare the characteristics of clinical and induced VT throughout multiple procedures and clarify their relations.
Of 425 consecutive patients with structural heart disease who underwent catheter VT ablation, second, third and fourth procedures were performed in 101, 23, and 5 patients, respectively. Of 227 VTs that were induced during the second procedure, 68 (30%) VTs had previously been induced at the first procedure. In multivariable analysis, identification of an exit/isthmus site (HR = 0.29, P = 0.047), early termination of VT during radiofrequency application (HR 0.11, P = 0.037) and elimination of target VT at the end of first procedure (HR = 0.43, P = 0.036) were independently associated with noninducibility of the same VT at the second procedure. Over the course of multiple procedures the mean VT cycle length gradually lengthened (381 ± 107, 413 ± 111, 460 ± 124, 507 ± 99 milliseconds in first, second, third, and fourth procedure, respectively, P < 0.001) and more induced VTs became mappable (32%, 40%, 62%, and 70% in first, second, third, and fourth procedure, respectively, P < 0.001).
Identification and ablation of VT exit/isthmus, early termination of VT during radiofrequency application and elimination of targeted VT are associated with absence of that VT during a repeat procedure, and recurrences are then mostly due to new VTs or other VTs that were not induced at the first procedure.
室性心动过速(VT)导管消融的最佳手术终点尚未明确,有时需要多次重复手术。然而,很少有研究比较重复手术与初次手术的细节。本研究的目的是比较多次手术中临床和诱发室性心动过速的特征,并阐明它们之间的关系。
在425例连续接受导管室性心动过速消融的结构性心脏病患者中,分别有101例、23例和5例患者接受了第二次、第三次和第四次手术。在第二次手术中诱发的227次室性心动过速中,68次(30%)室性心动过速在第一次手术中曾被诱发。在多变量分析中,识别出口/峡部部位(HR = 0.29,P = 0.047)、射频应用期间室性心动过速的早期终止(HR 0.11,P = 0.037)以及初次手术结束时目标室性心动过速的消除(HR = 0.43,P = 0.036)与第二次手术中相同室性心动过速的不可诱发性独立相关。在多次手术过程中,平均室性心动过速周期长度逐渐延长(第一次、第二次、第三次和第四次手术分别为381±107、413±111、460±124和507±99毫秒,P < 0.001),更多诱发的室性心动过速变得可标测(第一次、第二次、第三次和第四次手术分别为32%、40%、62%和70%,P < 0.001)。
室性心动过速出口/峡部的识别与消融、射频应用期间室性心动过速的早期终止以及目标室性心动过速的消除与重复手术期间该室性心动过速的不存在相关,复发主要是由于新的室性心动过速或第一次手术中未诱发的其他室性心动过速。